2003
DOI: 10.1017/s0317167100002584
|View full text |Cite
|
Sign up to set email alerts
|

Cannabis Use as Described by People with Multiple Sclerosis

Abstract: Multiple sclerosis (MS) is a recurrent inflammation of the central nervous system white matter leading to myelin destruction and progressive neurological impairment.1 T h e prevalence of MS in Alberta has been described as high with an overall crude rate of 217 per 100,000 population. 2 The available treatments for symptom management are of limited effectiveness and for many, have unpleasant side effects. 3Interest in cannabis as a therapeutic option for people with MS has coincided with the increasing accepta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
49
2
2

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(61 citation statements)
references
References 22 publications
8
49
2
2
Order By: Relevance
“…The prevalence of ever-users (43%) and medicinal users (17.1%) of cannabis in our MS patients was similar to other surveys in Canada, UK, USA, and The Netherlands (ranging from 36 to 43%, and from 12 to 22%, respectively) [5,[8][9][10][11]. The response rate in our study was very high (95%), thus reducing any possible influence of more motivated patients.…”
Section: Discussionsupporting
confidence: 87%
“…The prevalence of ever-users (43%) and medicinal users (17.1%) of cannabis in our MS patients was similar to other surveys in Canada, UK, USA, and The Netherlands (ranging from 36 to 43%, and from 12 to 22%, respectively) [5,[8][9][10][11]. The response rate in our study was very high (95%), thus reducing any possible influence of more motivated patients.…”
Section: Discussionsupporting
confidence: 87%
“…Claims from multiple sclerosis patients that self-medication with cannabis ameliorates symptoms are also found in a number of more recent anecdotal reports [35][36][37][38][39].…”
Section: Cannabinoid Receptor Agonists and The Management Of Multiplementioning
confidence: 95%
“…There are studies underway. In the meantime, it is important for physicians in Canada to be aware that 10% to 16% of patients presenting to pain and MS clinics are using cannabis for symptom control, and that pain is one of the top symptoms for which people in the general population are using cannabis for medical purposes (277)(278)(279)(280). Physicians should always ask about the use of cannabis and any other herbal or complementary therapies as a routine part of history-taking.…”
Section: Marihuana Medical Access Regulationsmentioning
confidence: 99%